Arxis Completes the Acquisition of Omnetics Connector Corporation
Long ARXS; expect multi-year EBITDA accretion from Omnetics and MagCanica, with near-term dilution risk.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Long ARXS; expect multi-year EBITDA accretion from Omnetics and MagCanica, with near-term dilution risk.
What happened and why it matters
Arxis announced the completion of its Omnetics Connector Corporation acquisition for about $770 million in enterprise value. The deal includes issuing 13.35 million ARXS Class A shares to Omnetics holders, representing roughly 3.1% of outstanding stock and subject to lockups. The combined entity trades at approximately 12x FY27 estimated adjusted EBITDA, signaling a strategic expansion into mission-critical connectors for defense, space, and medical markets with Arcline backing.
Strategic expansion into defense/space connectors, backed by Arcline, supports longer-term growth; 12x FY27 EBITDA implies potential valuation uplift if synergies materialize. Moderate near-term dilution is offset by accretion potential and expanded addressable markets.
Arxis completes Omnetics acquisition; enterprise value around $770 million.
Arxis issued 13,351,964 Class A shares (~3.1% of total) to Omnetics sellers.
Combined 12x FY27 estimated adjusted EBITDA; includes MagCanica acquisition.
Omnetics adds high-rel Micro-D/Nano-D connectors for defense/space/medical.
Arcline’s support broadens Arxis’ market mapping and sourcing capabilities.
Category: M&A. The press release centers on the completed Omnetics acquisition and its strategic implications, including valuation metrics and integration benefits within Arxis’ Electronic Components segment, aligned with Arcline’s value-creation playbook.
More AI-analyzed coverage connected to this story